One-third of antimalarial medicines sampled in three African nations found to be substandard

The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria.

Read the whole article on Science Daily

More from Science Daily